FI50416B - - Google Patents

Info

Publication number
FI50416B
FI50416B FI304067A FI304067A FI50416B FI 50416 B FI50416 B FI 50416B FI 304067 A FI304067 A FI 304067A FI 304067 A FI304067 A FI 304067A FI 50416 B FI50416 B FI 50416B
Authority
FI
Finland
Application number
FI304067A
Other languages
Finnish (fi)
Other versions
FI50416C (fi
Inventor
Kevan Brown
John Frederick Cavalla
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB51823/66A external-priority patent/GB1145884A/en
Priority claimed from GB5620366A external-priority patent/GB1206403A/en
Priority claimed from GB2626267A external-priority patent/GB1147626A/en
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Application granted granted Critical
Publication of FI50416B publication Critical patent/FI50416B/fi
Publication of FI50416C publication Critical patent/FI50416C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02—Holding devices, e.g. on the body
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI304067A 1966-11-18 1967-11-10 Menetelmä uusien terapeuttisesti käytettävien trisubstituoitujen oksat solien ja tiatsolien ja näiden happoadditiosuolojen valmistamiseksi FI50416C (fi)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB51823/66A GB1145884A (en) 1966-11-18 1966-11-18 Thiazole derivatives
GB5620366A GB1206403A (en) 1966-12-15 1966-12-15 Oxazoles
GB2507667 1967-05-31
GB2626267A GB1147626A (en) 1966-07-15 1967-06-07 Thiazole derivatives
GB2738267 1967-06-14

Publications (2)

Publication Number Publication Date
FI50416B true FI50416B (en:Method) 1975-12-01
FI50416C FI50416C (fi) 1976-03-10

Family

ID=27516268

Family Applications (1)

Application Number Title Priority Date Filing Date
FI304067A FI50416C (fi) 1966-11-18 1967-11-10 Menetelmä uusien terapeuttisesti käytettävien trisubstituoitujen oksat solien ja tiatsolien ja näiden happoadditiosuolojen valmistamiseksi

Country Status (12)

Country Link
JP (1) JPS4938267B1 (en:Method)
BE (1) BE706625A (en:Method)
CH (9) CH554884A (en:Method)
DE (2) DE1670005C2 (en:Method)
ES (1) ES347319A1 (en:Method)
FI (1) FI50416C (en:Method)
FR (2) FR1584222A (en:Method)
IL (1) IL28803A (en:Method)
LU (1) LU54891A1 (en:Method)
NL (1) NL157012B (en:Method)
PL (1) PL72562B1 (en:Method)
SE (2) SE369307B (en:Method)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096994A1 (en) * 1970-07-24 1972-03-03 Roussel Uclaf 2-para-cyclopropyl phenyl-4-(halo)phenyl-5-thiazolyl - alkanoic acids -antiinflammatory analgesic, antipyretic agents
JPS5113375U (en:Method) * 1974-07-18 1976-01-30
JPS5182675A (en:Method) * 1975-01-17 1976-07-20 Tokyo Shibaura Electric Co
GB1543154A (en) * 1975-05-02 1979-03-28 Lilly Industries Ltd Urea and carbamate derivatives
US4168315A (en) * 1977-09-28 1979-09-18 The Upjohn Company Dianisyl thiazole compound, compositions and method of antithrombotic treatment
US4697012A (en) * 1984-07-25 1987-09-29 Merck & Co., Inc. Morpholino pyridyl thiazole compound
IT1204751B (it) * 1986-01-03 1989-03-10 Therapicon Srl Derivati idrosolubili dell'acido 4,5 -difenil- 2 -ossazolpropionico,loro preparazione ed utilizzo in composizioni farmaceutiche
ES2245660T3 (es) * 1990-11-30 2006-01-16 Otsuka Pharmaceutical Co., Ltd. Derivados de azol y su utilizacion como inhibidores de los radicales superoxidos.
JPH10504542A (ja) * 1994-07-27 1998-05-06 ジー．ディー．サール アンド カンパニー 炎症処置用の置換チアゾール化合物
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130759C (en:Method) * 1965-10-07

Also Published As

Publication number Publication date
IL28803A (en) 1974-05-16
FI50416C (fi) 1976-03-10
LU54891A1 (en:Method) 1968-02-08
FR1584222A (en:Method) 1969-12-19
BE706625A (en:Method) 1968-05-16
CH560203A5 (en:Method) 1975-03-27
CH545309A (de) 1973-12-15
DE1670005C2 (de) 1982-06-09
DE1670005A1 (de) 1970-08-06
PL72562B1 (en) 1974-08-30
CH528531A (de) 1972-09-30
FR8018M (en:Method) 1970-08-03
NL6715532A (en:Method) 1968-05-20
CH560205A5 (en:Method) 1975-03-27
CH536311A (de) 1973-04-30
SE369307B (en:Method) 1974-08-19
NL157012B (nl) 1978-06-15
CH554884A (de) 1974-10-15
DE1795822C2 (de) 1982-07-15
JPS4938267B1 (en:Method) 1974-10-16
SE422209B (sv) 1982-02-22
ES347319A1 (es) 1969-05-16
CH545308A (de) 1973-12-15
CH545310A (de) 1973-12-15
CH556351A (de) 1974-11-29

Similar Documents

Publication Publication Date Title
FR8018M (en:Method)
AT281852B (en:Method)
AU424443B2 (en:Method)
AU1534566A (en:Method)
BE689977A (en:Method)
AU1111066A (en:Method)
AU218666A (en:Method)
AU1144366A (en:Method)
AU1393566A (en:Method)
BE624223A (en:Method)
BE674882A (en:Method)
AU1027866A (en:Method)
BE693497A (en:Method)
BE693536A (en:Method)
BE693788A (en:Method)
BE694368A (en:Method)
BE597652A (en:Method)
BE689163A (en:Method)
BE687690A (en:Method)
BE683740A (en:Method)
BE675173A (en:Method)
BE675139A (en:Method)
BE675084A (en:Method)
BE674987A (en:Method)
BE692247A (en:Method)